Attenuated Subcomponent Vaccine Design Targeting the SARS-CoV-2 Nucleocapsid Phosphoprotein RNA Binding Domain: In Silico Analysis

Figure 10

In silico cloning of the final vaccine construct into an expression vector where the red part indicates the coding gene for the vaccine enzymatically restricted by PasI.